339 related articles for article (PubMed ID: 23834141)
1. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews.
Hartmann-Boyce J; Stead LF; Cahill K; Lancaster T
Addiction; 2013 Oct; 108(10):1711-21. PubMed ID: 23834141
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.
Hartmann-Boyce J; Stead LF; Cahill K; Lancaster T
Addiction; 2014 Sep; 109(9):1414-25. PubMed ID: 24995905
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Cahill K; Stevens S; Perera R; Lancaster T
Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
[TBL] [Abstract][Full Text] [Related]
4. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A
Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822
[TBL] [Abstract][Full Text] [Related]
5. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.
Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Dec; 12():CD009670. PubMed ID: 23235680
[TBL] [Abstract][Full Text] [Related]
6. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
Stead LF; Koilpillai P; Lancaster T
Cochrane Database Syst Rev; 2015 Oct; (10):CD009670. PubMed ID: 26457723
[TBL] [Abstract][Full Text] [Related]
7. An update on therapeutics for tobacco dependence.
Lancaster T; Stead L; Cahill K
Expert Opin Pharmacother; 2008 Jan; 9(1):15-22. PubMed ID: 18076335
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effectiveness of cytisine for the treatment of smoking cessation: A systematic review and meta-analysis.
De Santi O; Orellana M; Di Niro CA; Greco V
Addiction; 2024 Apr; 119(4):649-663. PubMed ID: 38161271
[TBL] [Abstract][Full Text] [Related]
9. Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation.
Tutka P
Expert Opin Investig Drugs; 2008 Oct; 17(10):1473-85. PubMed ID: 18808308
[TBL] [Abstract][Full Text] [Related]
10. Tobacco smoking cessation management: integrating varenicline in current practice.
Galanti LM
Vasc Health Risk Manag; 2008; 4(4):837-45. PubMed ID: 19066000
[TBL] [Abstract][Full Text] [Related]
11. [Drugs used to treat nicotine addiction].
Zieleń I; Sliwińska-Mossoń M; Milnerowicz H
Przegl Lek; 2012; 69(10):1098-102. PubMed ID: 23421099
[TBL] [Abstract][Full Text] [Related]
12. Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines.
Reus VI; Smith BJ
Int J Clin Pract; 2008 Nov; 62(11):1753-68. PubMed ID: 18795968
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis.
Myung SK; Ju W; Jung HS; Park CH; Oh SW; Seo H; Kim H;
BJOG; 2012 Aug; 119(9):1029-39. PubMed ID: 22780818
[TBL] [Abstract][Full Text] [Related]
14. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
[TBL] [Abstract][Full Text] [Related]
15. Cytisine for smoking cessation: A systematic review and meta-analysis.
Ofori S; Lu C; Olasupo OO; Dennis BB; Fairbairn N; Devereaux PJ; Mbuagbaw L
Drug Alcohol Depend; 2023 Oct; 251():110936. PubMed ID: 37678096
[TBL] [Abstract][Full Text] [Related]
16. Interventions for Tobacco Cessation in Adults, Including Pregnant Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Patnode CD; Henderson JT; Coppola EL; Melnikow J; Durbin S; Thomas RG
JAMA; 2021 Jan; 325(3):280-298. PubMed ID: 33464342
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
[TBL] [Abstract][Full Text] [Related]
18. Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation.
Tutka P; Vinnikov D; Courtney RJ; Benowitz NL
Addiction; 2019 Nov; 114(11):1951-1969. PubMed ID: 31240783
[TBL] [Abstract][Full Text] [Related]
19. Cytisine for smoking cessation: a research agenda.
Etter JF; Lukas RJ; Benowitz NL; West R; Dresler CM
Drug Alcohol Depend; 2008 Jan; 92(1-3):3-8. PubMed ID: 17825502
[TBL] [Abstract][Full Text] [Related]
20. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
Lam S; Patel PN
Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
